⌕
Globus Medical · GMED · NYSE
Tenet 77 · Strong
Compare
$69.99−0.72%At closeTenet 77 · Strong
$69.99−0.51 (−0.72%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Globus Medical (GMED) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is GMED's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● GlobeNewsWireNov 9, 2026 · 16:02 ETCOMPANY'S OWN WORDS
Globus Medical to Participate in Jefferies Global Healthcare Conference

AUDUBON, Pa., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Jefferies Global Healthcare Conferenc…

GMED −0.7% todayRead at source ↗
● MarketBeatNov 7, 2026 · 06:26 ET
Globus Medical Q3 Earnings Call Highlights

Globus Medical NYSE: GMED lowered its 2026 revenue forecast after third-quarter sales fell, citing continued declines at its Nevro business, delayed spine product launches and lower contributions from competitive sales r…

GMED −0.7% todayRead at source ↗
● Zacks Investment ResearchNov 6, 2026 · 11:01 ET
GMED Q3 Earnings Call Highlights Guidance Cut and 2027 Reset

Globus Medical cuts its 2026 revenue outlook amid spine launch delays and weak Nevro sales while shifting its focus to new products and growth opportunities in 2027.…

GMED −0.7% todayRead at source ↗
● Seeking AlphaNov 5, 2026 · 20:44 ET
Globus Medical, Inc. (GMED) Q3 2026 Earnings Call Transcript

Globus Medical, Inc. (GMED) Q3 2026 Earnings Call Transcript…

GMED −0.7% todayRead at source ↗
● Zacks Investment ResearchNov 5, 2026 · 20:31 ET
Compared to Estimates, Globus Medical (GMED) Q3 Earnings: A Look at Key Metrics

The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the…

GMED −0.7% todayRead at source ↗
● Zacks Investment ResearchNov 5, 2026 · 18:46 ET
Globus Medical (GMED) Q3 Earnings Top Estimates

Globus Medical (GMED) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.2 per share. This compares to earnings of $1.18 per share a year ago.…

GMED −0.7% todayRead at source ↗
● GlobeNewsWireNov 5, 2026 · 16:02 ETCOMPANY'S OWN WORDS
Globus Medical Reports Third Quarter 2026 Results and Announces a $500 Million Increase to the Share Repurchase Program

AUDUBON, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the third quarter ended September 30, 2026.…

GMED −0.7% todayRead at source ↗
● Seeking AlphaNov 2, 2026 · 12:57 ET
Globus Medical: The Shrinking Robot Line Hides A Growing Annuity

Globus Medical is leveraging flexible leasing models to expand its installed base, prioritizing recurring high-margin implant sales over upfront capital revenue. GMED's post-NuVasive integration is driving structurally h…

GMED −0.7% todayRead at source ↗
● Zacks Investment ResearchNov 2, 2026 · 12:41 ET
GMED vs. AXGN: Which Stock Should Value Investors Buy Now?

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and AxoGen (AXGN). But which of these two companies is the best option for those looking for under…

GMED −0.7% todayRead at source ↗
● Zacks Investment ResearchNov 2, 2026 · 10:55 ET
Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet

The consensus price target hints at a 30.5% upside potential for Globus Medical (GMED). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions cou…

GMED −0.7% todayRead at source ↗
● Zacks Investment ResearchNov 2, 2026 · 10:51 ET
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

GMED −0.7% todayRead at source ↗
● Zacks Investment ResearchOct 29, 2026 · 09:46 ET
2 Healthcare Technology Stocks for a Digital Health Boom

GMED and STE offer exposure to healthcare technology growth, with projected 2026 EPS gains, attractive valuations and innovations in essential medical services.…

GMED −0.7% todayRead at source ↗
● Defense WorldOct 27, 2026 · 03:59 ET
Gibbs Wealth Management Purchases 7,829 Shares of Globus Medical, Inc. $GMED

Gibbs Wealth Management purchased a new position in shares of Globus Medical, Inc. (NYSE: GMED) during a recent quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 7,829 shares of the m…

GMED −0.7% todayRead at source ↗
● PRNewsWireOct 21, 2026 · 16:26 ET
Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm

NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Globus Medical, Inc. (NYSE: GMED) breached their fiduciary duties to …

GMED −0.7% todayRead at source ↗
● Zacks Investment ResearchOct 21, 2026 · 10:41 ET
Globus Medical (GMED) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

GMED −0.7% todayRead at source ↗
● Zacks Investment ResearchOct 16, 2026 · 12:40 ET
GMED or AXGN: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or AxoGen (AXGN). But which of these two stocks offers value investors a better bang for their buck rig…

GMED −0.7% todayRead at source ↗
● GlobeNewsWireOct 14, 2026 · 08:00 ETCOMPANY'S OWN WORDS
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026

AUDUBON, Pa., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will highlight its latest spine innovations at the 41st Annual North Ame…

GMED −0.7% todayRead at source ↗
● GlobeNewsWireOct 12, 2026 · 16:01 ETCOMPANY'S OWN WORDS
Globus Medical Schedules Third Quarter Earnings Release and Conference Call

AUDUBON, Pa., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended September 30, 2026 after the…

GMED −0.7% todayRead at source ↗
● Zacks Investment ResearchOct 7, 2026 · 10:56 ET
Reasons to Add Globus Medical Stock to Your Portfolio Now

GMED gains musculoskeletal share on strong spine and trauma growth, while product innovation and a debt-free balance sheet support its appeal.…

GMED −0.7% todayRead at source ↗
● Zacks Investment ResearchOct 6, 2026 · 02:55 ET
Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific

Globus Medical, Intuitive Surgical and Thermo Fisher Scientific have been highlighted in this Industry Outlook article.…

GMED −0.7% todayRead at source ↗
● Zacks Investment ResearchOct 5, 2026 · 10:41 ET
Here's Why Globus Medical (GMED) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.…

GMED −0.7% todayRead at source ↗
● Zacks Investment ResearchOct 5, 2026 · 10:20 ET
3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes

GenAI offers growth opportunities for GMED, ISRG and TMO, but evolving regulations and industry risks are likely to shape adoption.…

GMED −0.7% todayRead at source ↗
● Zacks Investment ResearchSep 30, 2026 · 12:41 ET
GMED vs. ITGR: Which Stock Is the Better Value Option?

Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Integer (ITGR). But which of these two stocks offers value investors a better bang for their buck right now?…

GMED −0.7% todayRead at source ↗
● Zacks Investment ResearchSep 16, 2026 · 13:01 ET
What Makes Globus Medical (GMED) a New Strong Buy Stock

Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).…

GMED −0.7% todayRead at source ↗
● GlobeNewsWireSep 3, 2026 · 16:30 ETCOMPANY'S OWN WORDS
Globus Medical Announces CE Mark for Excelsius3D™ Imaging System

Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem in the European Union Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem in the European Union…

GMED −0.7% todayRead at source ↗
● GlobeNewsWireAug 26, 2026 · 17:57 ETCOMPANY'S OWN WORDS
Globus Medical Announces Acquisition of Higgs Boson Health to Transform Healthcare Experience Through AI-Driven Digital Solutions

AUDUBON, Pa., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the acquisition of Higgs Boson Health, a digital healthcare experience comp…

GMED −0.7% todayRead at source ↗

No upcoming events in the feeds.

NVDA36−0.4%
INTC4−0.5%
LAW4−8.6%
ABR3−2.6%

Article counts from the last market-wide feed page, across every symbol we track and not just GMED · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.